版本:
中国

BRIEF-Egalet, units enter into agreement with Halo Pharma

March 6 Egalet Corp:

* Egalet - on Feb 28, co and its units entered into a drug product manufacturing services agreement with Halo Pharmaceutical, Inc - SEC filing

* Egalet Corp - co engaged Halo to provide certain services related to manufacture, supply of arymotm er tablets for co's commercial use in United States

* Egalet Corp - term of agreement is five years from date of Egalet's first firm order for product

* Egalet - is obligated to purchase all of its requirements for product from Halo through 2019, and 75 percent of its requirements thereafter

* Egalet Corp - agreement will automatically extend for successive 2-year renewal terms Source text: (bit.ly/2lPvWGr) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐